← Blog

Nanotechnology in Wound Healing: The Essential Fundamentals

Published on 2025-10-15 · PT Jefferson Ramírez

Wound healing represents one of the most significant challenges in modern medicine, especially in patients with diabetes, extensive burns or chronic wounds. Nanotechnology has emerged as a revolutionary solution, offering materials with superior antimicrobial properties, controlled drug-release capabilities and structures that mimic the tissue's natural extracellular matrix.

This article presents the fundamental concepts that make up 80% of the essential knowledge in this field, following the Pareto principle applied to scientific research.

1. Silver Nanoparticles (AgNPs): The Antimicrobial Standard

Silver nanoparticles are the most studied and most widely commercialized antimicrobial nanomaterial in wound treatment. Their effectiveness is based on multiple simultaneous mechanisms of action.

Mechanisms of Action

• Release of Ag+ ions: Interaction with thiol groups (-SH) in bacterial proteins
• Damage to cell membranes: Alteration of bacterial permeability
• Generation of reactive oxygen species (ROS): Intracellular oxidative stress
• Interference with DNA replication: Inhibition of bacterial division

Clinical Applications

AgNPs are incorporated into commercial dressings such as Acticoat™ and Silvercel™, showing efficacy against multidrug-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (Rai et al., 2009).

Safety Considerations

Despite their efficacy, there is concern about cytotoxicity in mammalian cells and tissue accumulation. Optimizing size (10-50 nm) and concentration is crucial to maximize the therapeutic index (Sharma et al., 2009).

2. Electrospun Nanofibers: Mimicking the Extracellular Matrix

Electrospinning technology produces nanofibers that replicate the three-dimensional architecture of the natural extracellular matrix (ECM), providing an ideal substrate for cell migration and proliferation.

Structural Characteristics

• Diameter: 50-500 nm
• Porosity: 60-90%
• Surface area: 10-100 m²/g
• Orientation: Aligned or random depending on the application

Common Materials

• Synthetic polymers: Polycaprolactone (PCL), polylactic acid (PLA), polyvinyl alcohol (PVA)
• Natural polymers: Collagen, chitosan, gelatin, hyaluronic acid
• Hybrids: Combinations that balance mechanical properties and biodegradability

Biological Advantages

Nanofibers facilitate cell adhesion, allow the exchange of nutrients and oxygen, absorb exudates and can be loaded with bioactive agents for controlled release (Xue et al., 2019).

3. Nanocomposite Hydrogels: A Smart Moist Microenvironment

Hydrogels are three-dimensional platforms with high water content (70-99%) that maintain the optimal moist environment for healing while providing additional functionality through incorporated nanoparticles.

Key Properties

• Swelling: Ability to absorb 10-1000 times their weight in water
• Biocompatibility: Minimal inflammatory response
• Adhesiveness: Conforms to irregular surfaces
• Transparency: Visual monitoring of the wound

Functional Nanocomposites

Incorporating silver nanoparticles, zinc oxide or carbon nanotubes provides antimicrobial properties, while gold or superparamagnetic nanoparticles enable photothermal or targeted therapies (Zhao et al., 2017).

Base Materials

Alginate, chitosan, PVA, PEG and their combinations dominate commercial and experimental formulations because of their balance between mechanical properties and degradability.

4. Nanostructured Metal Oxides: Beyond Silver

Metal nanooxides offer alternatives or complements to AgNPs, with unique activity profiles and, in some cases, lower cost.

Zinc Oxide (ZnO)

• Antimicrobial: Effective against Gram+ and Gram- bacteria
• Pro-angiogenic: Stimulates the formation of new blood vessels
• Photoprotective: Absorbs UV radiation
• Lower cytotoxicity compared to AgNPs at equivalent concentrations (Mirzaei & Darroudi, 2017)

Titanium Oxide (TiO₂)

• Photocatalytic activity: Generates ROS under UV/visible light
• Biocompatibility: Widely used in implants
• Sustained antimicrobial effect

Copper Oxide (CuO)

• Potent antimicrobial: Superior to ZnO against some strains
• Pro-angiogenic: Cu²⁺ ions stimulate vascular endothelial growth factor (VEGF)
• Cost-effective: Lower price than silver or gold

5. Nanoencapsulated Controlled-Release Systems

Nanoscale encapsulation makes it possible to protect sensitive bioactive molecules and control their release in time and space.

Encapsulation Platforms

Liposomes

• Lipid bilayer vesicles (50-500 nm)
• Encapsulate hydrophilic and lipophilic molecules
• High biocompatibility
• Release by fusion with cell membranes

Polymeric Nanoparticles

• PLGA (poly-lactic-co-glycolic acid): biodegradable, FDA-approved
• Chitosan: mucoadhesive, intrinsically antimicrobial
• Release by diffusion and/or polymer degradation

Dendrimers

• Hyperbranched structures (1-10 nm)
• High loading capacity
• Surface functionalization for targeting

Encapsulated Molecules

• Growth factors: EGF, FGF, PDGF, VEGF
• Antibiotics: Gentamicin, vancomycin, ciprofloxacin
• Anti-inflammatories: Dexamethasone, curcumin
• Antioxidants: Vitamin E, resveratrol

Sustained release (days to weeks) improves therapeutic efficacy while reducing application frequency and systemic adverse effects (Boateng et al., 2008).

6. Bioactive Nanocomposite Scaffolds: Tissue Engineering

Three-dimensional scaffolds provide temporary structural support while guiding the regeneration of native tissue, eventually degrading without leaving residues.

Design Requirements

• Interconnected porosity: 50-90%, pores of 100-500 μm for vascularization
• Mechanical properties: Matching native tissue (skin: 2-20 MPa)
• Controlled degradation: Kinetics synchronized with tissue neogenesis
• Bioactivity: Chemical and topographic signals for cells

Advanced Fabrication

• Electrospinning: Nonwoven nanofibers
• 3D printing: Customized architectures
• Freeze-drying: Sponge-like structures
• Self-assembly: Spontaneous molecular organization

Bioactive Nanocomponents

Incorporating hydroxyapatite nanocrystals (for hardness), carbon nanotubes (for conductivity) or bioglass nanoparticles (for bioactivity) improves the functionality of the base scaffold (Augustine et al., 2014).

7. Critical Physicochemical Properties

Nanoscale properties fundamentally determine the biological behavior of materials.

Particle Size

• 1-10 nm: Deep cellular penetration, possible toxicity
• 10-100 nm: Optimal range for cellular interaction without excessive toxicity
• >100 nm: Lower penetration, predominantly surface activity

Surface Area

The exponentially increased surface-to-volume ratio at the nanoscale results in:

• Greater chemical reactivity
• Greater drug-loading capacity
• Increased protein-surface interactions

Surface Charge (Zeta Potential)

• Cationic (+): Interaction with negative bacterial membranes, greater cytotoxicity
• Anionic (-): Less cellular interaction, better biocompatibility
• Neutral: Lower cellular uptake, longer circulation time

Shape

Spheres, rods, tubes, plates and irregular shapes exhibit different patterns of cellular internalization and biodistribution (Elahi et al., 2013).

8. Mechanisms of Action in the Phases of Healing

Wound healing proceeds through four overlapping phases. Nanomaterials can optimize each one.

Hemostatic Phase (First Hours)

• Hemostatic nanoparticles: Silica and chitosan accelerate coagulation
• Nanoencapsulated vasoconstrictors: Bleeding control

Inflammatory Phase (Days 1-5)

• Nanostructured antimicrobials: AgNPs and ZnO prevent infection
• Encapsulated antioxidants: Modulate excessive inflammation
• Macrophage targeting: Nanoparticles for M1→M2 polarization

Proliferative Phase (Days 4-21)

• Nanoencapsulated growth factors: EGF and FGF stimulate proliferation
• Nanofibrous scaffolds: Support for the migration of keratinocytes and fibroblasts
• Pro-angiogenic nanoparticles: CuO and ZnO promote vascularization

Remodeling Phase (Weeks to Months)

• Biodegradable scaffolds: Degradation synchronized with ECM deposition
• Nanoencapsulated collagen modulators: Optimize the type I/III collagen ratio
• Anti-fibrotic nanoparticles: Prevent hypertrophic scarring

The ability to design nanomaterials that act specifically in each phase represents the greatest potential of this technology (Guo et al., 2010).

Commercial Products and Clinical Translation

Silver-Based Products

• Acticoat™ (Smith & Nephew): Silver nanoparticles in a polyethylene mesh
• Silvercel™ (Acelity): Alginate/carboxymethylcellulose fibers with silver
• Aquacel™ Ag (ConvaTec): Hydrofibers with silver ions

Advanced Matrix Products

• Integra™: Collagen-glycosaminoglycan scaffold with controlled nanostructure
• Matristem™: Extracellular matrix of porcine origin with preserved nanofibrous architecture

In Clinical Development

Multiple nanocomposite hydrogel formulations, dressings with controlled release of growth factors and bioprintable scaffolds are currently in clinical trial phases.

Challenges and Future Perspectives

Current Challenges

1. Standardization: Lack of unified characterization and testing protocols
2. Scalability: Transition from laboratory to industrial manufacturing
3. Regulation: Regulatory frameworks for nanomedicines are still under development
4. Cost: Many technologies are not yet cost-effective for mass use
5. Long-term toxicology: Extended safety studies are needed

Emerging Trends

• Responsive nanomaterials: Release triggered by pH, temperature or enzymes in the wound microenvironment
• Theranostics: Systems that diagnose and treat simultaneously
• Bioprinting with nanomaterials: Customized complex tissues
• Artificial intelligence: Computational design of optimized nanoformulations
• Green nanomedicine: Eco-friendly synthesis using plant extracts

Conclusions

Nanotechnology has transformed the field of wound healing, offering solutions to persistent clinical problems such as resistant infections, delayed healing and inadequate scarring. The eight fundamental concepts presented constitute the base of knowledge needed to understand and apply these technologies:

1. Silver nanoparticles dominate antimicrobial applications
2. Electrospun nanofibers successfully mimic the native ECM
3. Nanocomposite hydrogels provide smart therapeutic microenvironments
4. Metal oxides offer multifunctional alternatives
5. Nanoencapsulation enables optimized drug therapy
6. Bioactive scaffolds facilitate true tissue regeneration
7. Physicochemical properties determine biological behavior
8. Phase-specific intervention in healing maximizes results

The future of this field promises increasingly smart, personalized and effective materials, with the potential to transform chronic wounds from a major public health problem into manageable conditions with a high quality of life for patients.

References

Augustine, R., Kalarikkal, N., & Thomas, S. (2014). Advancement of wound care from grafts to bioengineered smart skin substitutes. Progress in Biomaterials, 3(2-4), 103-113.

Boateng, J. S., Matthews, K. H., Stevens, H. N., & Eccleston, G. M. (2008). Wound healing dressings and drug delivery systems: a review. Journal of Pharmaceutical Sciences, 97(8), 2892-2923.

Elahi, N., Kamali, M., & Baghersad, M. H. (2013). Recent biomedical applications of gold nanoparticles: A review. Talanta, 184, 537-556.

Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of Dental Research, 89(3), 219-229.

Mirzaei, H., & Darroudi, M. (2017). Zinc oxide nanoparticles: Biological synthesis and biomedical applications. Ceramics International, 43(1), 907-914.

Rai, M., Yadav, A., & Gade, A. (2009). Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances, 27(1), 76-83.

Sharma, V. K., Yngard, R. A., & Lin, Y. (2009). Silver nanoparticles: green synthesis and their antimicrobial activities. Advances in Colloid and Interface Science, 145(1-